HSF1 and neoplasm: Moreover, the lncRNA inducing MHC‐I and immunogenicity of tumour (LIMIT) enhances tumour immunogenicity by activating the GBP gene cluster, which disrupts the HSF1 association, leading to HSF1‐mediated transcription of MHC‐I machinery.